» Articles » PMID: 30364389

Tuberculosis Preventive Treatment: the Next Chapter of Tuberculosis Elimination in India

Abstract

The End TB Strategy envisions a world free of tuberculosis-zero deaths, disease and suffering due to tuberculosis by 2035. This requires reducing the global tuberculosis incidence from >1250 cases per million people to <100 cases per million people within the next two decades. Expanding testing and treatment of tuberculosis infection is critical to achieving this goal. In high-burden countries, like India, the implementation of tuberculosis preventive treatment (TPT) remains a low priority. In this analysis article, we explore potential challenges and solutions of implementing TPT in India. The next chapter in tuberculosis elimination in India will require cost-effective and sustainable interventions aimed at tuberculosis infection. This will require constant innovation, locally driven solutions to address the diverse and dynamic tuberculosis epidemiology and persistent programme monitoring and evaluation. As new tools, regimens and approaches emerge, midcourse adjustments to policy and practice must be adopted. The development and implementation of new tools and strategies will call for close collaboration between local, national and international partners-both public and private-national health authorities, non-governmental organisations, research community and the diagnostic and pharmaceutical industry. Leading by example, India can contribute to global knowledge through operational research and programmatic implementation for combating tuberculosis infection.

Citing Articles

Advancing tuberculosis elimination in India: A qualitative review of current strategies and areas for improvement in tuberculosis preventive treatment.

Shah H, Patel J, Rai S, Sen A IJID Reg. 2025; 14:100556.

PMID: 39866845 PMC: 11761892. DOI: 10.1016/j.ijregi.2024.100556.


Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India.

Shah D, Bhide S, Deshmukh R, Smith J, Kaiplyawar S, Puri V Front Tuberc. 2024; 2.

PMID: 39421397 PMC: 11485165. DOI: 10.3389/ftubr.2024.1454277.


Outcomes and Challenges in the Programmatic Implementation of Tuberculosis Preventive Therapy among Household Contacts of Pulmonary TB Patients: A Mixed-Methods Study from a Rural District of Karnataka, India.

Samudyatha U, Soundappan K, Ramaswamy G, Mehta K, Kumar C, Jagadeesh M Trop Med Infect Dis. 2023; 8(12).

PMID: 38133444 PMC: 10748199. DOI: 10.3390/tropicalmed8120512.


Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis.

Vesga J, Lienhardt C, Nsengiyumva P, Campbell J, Oxlade O, den Boon S BMC Med. 2022; 20(1):182.

PMID: 35581650 PMC: 9115962. DOI: 10.1186/s12916-022-02378-1.


Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.

Kazibwe A, Oryokot B, Mugenyi L, Kagimu D, Oluka A, Kato D PLoS One. 2022; 17(5):e0266285.

PMID: 35576223 PMC: 9109920. DOI: 10.1371/journal.pone.0266285.


References
1.
Chadha V . Tuberculosis epidemiology in India: a review. Int J Tuberc Lung Dis. 2005; 9(10):1072-82. View

2.
Struminger B, Arora S, Zalud-Cerrato S, Lowrance D, Ellerbrock T . Building virtual communities of practice for health. Lancet. 2017; 390(10095):632-634. PMC: 6402556. DOI: 10.1016/S0140-6736(17)31666-5. View

3.
Whitworth W, Hamilton L, Goodwin D, Barrera C, West K, Racster L . Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests. PLoS One. 2012; 7(9):e43790. PMC: 3435391. DOI: 10.1371/journal.pone.0043790. View

4.
Nolan C, Goldberg S, Buskin S . Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA. 1999; 281(11):1014-8. DOI: 10.1001/jama.281.11.1014. View

5.
Powell 3rd R, Whitworth W, Bernardo J, Moonan P, Mazurek G . Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests. PLoS One. 2011; 6(6):e20061. PMC: 3110578. DOI: 10.1371/journal.pone.0020061. View